News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
528,477 Results
Type
Article (10099)
Company Profile (177)
Press Release (518110)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (179998)
Career Advice (370)
Deals (27755)
Drug Delivery (9)
Drug Development (61373)
Employer Resources (24)
FDA (10429)
Job Trends (9407)
News (260989)
Policy (19846)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (580)
Accelerated approval (26)
ADA (19)
Adcomms (1)
Allergies (116)
Alliances (36618)
ALS (133)
Alzheimer's disease (1081)
Antibody-drug conjugate (ADC) (348)
Approvals (11127)
Artificial intelligence (379)
ASCO (194)
Autoimmune disease (243)
Automation (33)
Bankruptcy (270)
Best Places to Work (7599)
BIO (44)
BIOSECURE Act (2)
Biosimilars (156)
BioSpace Insights (18)
Biotechnology (115)
Bladder cancer (152)
Brain cancer (39)
Breast cancer (532)
Cancer (4178)
Cardiovascular disease (254)
Career advice (306)
Career pathing (3)
CAR-T (221)
CDC (2)
Celiac Disease (1)
Cell therapy (567)
Cervical cancer (37)
Clinical research (55812)
Collaboration (1460)
Commercialization (2)
Compensation (1513)
Complete response letters (38)
COVID-19 (938)
CRISPR (65)
C-suite (883)
Cystic fibrosis (94)
Data (6473)
Denatured (4)
Depression (120)
Dermatology (69)
Diabetes (381)
Diagnostics (4298)
Digital health (38)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (186)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (169)
Earnings (77601)
Editorial (4)
Employer branding (3)
Employer resources (23)
Events (95865)
Executive appointments (830)
FDA (13387)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (27)
Funding (1064)
Gene editing (132)
Generative AI (15)
Gene therapy (342)
GLP-1 (399)
Government (1132)
Grass and pollen (3)
Guidances (321)
Healthcare (9882)
Hematology (129)
HIV (54)
Huntington's disease (26)
IgA nephropathy (68)
Immunology and inflammation (129)
Immuno-oncology (70)
Indications (176)
Infectious disease (1150)
Inflammatory bowel disease (154)
Inflation Reduction Act (5)
Influenza (93)
Intellectual property (263)
Interviews (49)
IPO (13511)
IRA (5)
Job creations (2198)
Job search strategy (289)
JPM (3)
Kidney cancer (20)
Labor market (1)
Layoffs (86)
Leadership (2)
Legal (5393)
Licensing (2)
Liver cancer (51)
Longevity (16)
Lung cancer (618)
Lymphoma (308)
Machine learning (33)
Management (7)
Manufacturing (655)
Marketing (10)
MASH (163)
Medical device (8745)
Medtech (8875)
Mergers & acquisitions (15324)
Metabolic disorders (827)
mRNA (60)
Multiple sclerosis (134)
NASH (7)
Neurodegenerative disease (261)
Neuropsychiatric disorders (50)
Neuroscience (2110)
NextGen: Class of 2026 (3362)
Non-profit (953)
Now hiring (4)
Obesity (258)
Opinion (32)
Ovarian cancer (168)
Pain (189)
Pancreatic cancer (205)
Parkinson's disease (249)
Partnered (11)
Patents (498)
Patient recruitment (605)
Peanut (45)
People (45072)
Pharmaceutical (40)
Pharmacy benefit managers (8)
Phase 1 (17819)
Phase 2 (24975)
Phase 3 (17083)
Pipeline (7755)
Policy (32)
Postmarket research (1706)
Preclinical (7319)
Press Release (41)
Prostate cancer (220)
Psychedelics (8)
Radiopharmaceuticals (247)
Rare diseases (650)
Real estate (3494)
Recruiting (12)
Regulatory (16820)
Reports (18)
Research institute (690)
Resumes & cover letters (48)
Rett syndrome (39)
RNA editing (5)
RSV (48)
Schizophrenia (139)
Series A (178)
Series B (137)
Service/supplier (4)
Sickle cell disease (67)
Spinal muscular atrophy (94)
Sponsored (8)
Startups (2294)
State (1)
Stomach cancer (3)
Supply chain (56)
Tariffs (7)
Vaccines (396)
Venture capital (23)
Weight loss (91)
Women's health (80)
Worklife (1)
Date
Last 7 days (398)
Last 30 days (1315)
Last 365 days (21800)
2026 (12802)
2025 (21840)
2024 (25723)
2023 (29817)
2022 (38095)
2021 (41036)
2020 (36807)
2019 (26116)
2018 (19675)
2017 (21428)
2016 (20439)
2015 (26745)
2014 (23465)
2013 (19516)
2012 (21437)
2011 (21676)
2010 (21478)
Location
Africa (278)
Alabama (84)
Alaska (2)
Arizona (313)
Arkansas (13)
Asia (24809)
Australia (3027)
California (12355)
Canada (3171)
China (1102)
Colorado (483)
Connecticut (452)
Delaware (315)
Europe (40418)
Florida (1851)
Georgia (374)
Hawaii (3)
Idaho (46)
Illinois (742)
India (61)
Indiana (374)
Iowa (14)
Japan (459)
Kansas (104)
Kentucky (30)
Louisiana (28)
Maine (26)
Maryland (1256)
Massachusetts (8402)
Michigan (303)
Minnesota (570)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (12)
Nevada (112)
New Hampshire (64)
New Jersey (2963)
New Mexico (15)
New York (3125)
North Carolina (1421)
North Dakota (4)
Northern California (6232)
Ohio (280)
Oklahoma (18)
Oregon (24)
Pennsylvania (2309)
Puerto Rico (24)
Rhode Island (32)
South America (479)
South Carolina (75)
South Dakota (1)
Southern California (5063)
Tennessee (117)
Texas (1929)
United States (41044)
Utah (364)
Vermont (1)
Virginia (165)
Washington D.C. (41)
Washington State (965)
West Virginia (1)
Wisconsin (83)
528,477 Results for "hanx biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
May 7, 2025
·
2 min read
Business
Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
Crown Bioscience has announced that its collaborative work with HanX Biopharmaceutical Co., Ltd. (“HanX”), employing a unique and broad portfolio of preclinical modeling in support of HanX’s successful FDA Investigational New Drug (IND) application, has been published in Scientific Reports, a journal within the Nature portfolio.
August 22, 2023
·
4 min read
HanX Biopharmaceuticals announces HX009 IND approval from FDA
Hanx Biopharmaceuticals, Inc. (HanxBio), announced that the company has received Investigational New Drug (IND) approval to start clinical trial of the potentially first-in-class recombinant anti-CD47/PD-1 bispecific antibody (BsAb), HX009, in Patients with relapsed/refractory Lymphoma.
May 22, 2023
·
2 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 2, 2025
·
2 min read
Press Releases
Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO
July 14, 2026
·
3 min read
Press Releases
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
·
5 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders
June 8, 2026
·
3 min read
Press Releases
DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer
July 7, 2026
·
3 min read
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.
July 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
May 27, 2026
·
9 min read
1 of 52,848
Next
